{"id":61971,"date":"2025-10-03T22:02:40","date_gmt":"2025-10-03T20:02:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/"},"modified":"2025-10-03T22:02:40","modified_gmt":"2025-10-03T20:02:40","slug":"built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/","title":{"rendered":"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand"},"content":{"rendered":"<div>\n<p>CHARLOTTESVILLE, Va.&#8211;(BUSINESS WIRE)&#8211;BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia\u2019s biotechnology ecosystem. The relocation of BUILT\u2019s headquarters to CvilleBioHub\u2019s state-of-the-art facilities at North Fork Research Park positions the company to rapidly scale production in a new, next-generation laboratory to meet exploding demand and to grow its team by tapping Charlottesville\u2019s talent pool.<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/5\/BUILT-logo-black.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/5\/BUILT-logo-black.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/21\/BUILT-logo-black.jpg\"><\/a><\/p>\n<p>\nThrough its breakthrough Regenerative DNA Assembly\u2122 process, BUILT is bridging the gap between DNA synthesis and ready-to-use DNA molecules for a growing roster of customers nationwide, from top-10 biopharma companies to university core facilities to small startups, enabling them to accelerate programs in cell and gene therapy, RNA therapeutics, and synthetic biology broadly.<\/p>\n<p>\nThe company routinely ships BUILT DNA\u2122: sequence-perfect DNA constructs, including \u201cunbuildable\u201d long and complex molecules, in linear and plasmid formats. BUILT\u2019s service provides biotech innovators with unparalleled capability, reliability, and speed, eliminating the need for in-house assembly and stepping up development timelines.<\/p>\n<p>\nGeorge McArthur, PhD, CEO of BUILT Biotechnologies, stated, \u201cOur designation as an anchor company at the Commonwealth BioAccelerator validates BUILT\u2019s rapid emergence as the partner of choice for the full range of life science operations seeking a more efficient and cost-effective way to access highest-quality, ready-built DNA. Our new North Fork lab will provide the capacity to scale and meet this pressing market need, as well as to recruit exceptional local talent and partner more closely with CvilleBioHub.\u201d<\/p>\n<p>\nWith its expanded presence at North Fork, BUILT is also positioned to collaborate with the new Paul and Diane Manning Institute of Biotechnology at the University of Virginia, underscoring the company\u2019s ability to serve innovators both globally and locally.<\/p>\n<p>\n\u201cBUILT exemplifies the kind of scale-ready company we\u2019re proud to champion in Central Virginia,\u201d said Nikki Hastings, PhD, Executive Director of CvilleBioHub. \u201cAs an anchor company of the Commonwealth BioAccelerator, BUILT strengthens our ecosystem by delivering the reliable, fast, and capable DNA manufacturing that growing therapeutics companies need to move from idea to impact.\u201d The Commonwealth BioAccelerator, operated by CvilleBioHub and supported by public and private partners, provides companies with the resources and community to scale in Virginia\u2019s biotech ecosystem.<\/p>\n<p>\n<b>About BUILT Biotechnologies<\/b><\/p>\n<p>\nBUILT is transforming the DNA supply chain with its centralized DNA Manufacturing-as-a-Service model, eliminating the need for in-house DNA assembly. Powered by its proprietary Regenerative DNA Assembly\u2122 platform, BUILT produces ready-to-use BUILT DNA\u2122 constructs, including previously \u201cunbuildable\u201d sequences, delivered with unmatched capability, reliability, and speed. BUILT is headquartered in Charlottesville, Virginia, and serves customers around the world. Contact us for your DNA needs \u2014 and embrace our promise: <i>Consider it BUILT. <\/i>To learn more, visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.builtdna.com&amp;esheet=54333803&amp;newsitemid=20251003054308&amp;lan=en-US&amp;anchor=www.builtdna.com&amp;index=1&amp;md5=9eadf4231de4524a94024bdbb6c125b5\" rel=\"nofollow\" shape=\"rect\">www.builtdna.com<\/a>.<\/p>\n<p>\n<b>About CvilleBioHub<\/b><\/p>\n<p>\nCvilleBioHub is accelerating the growth of the life sciences sector in Central Virginia. By supporting high-potential biotech startups, facilitating strategic connections, and building the infrastructure to commercialize academic research, CvilleBioHub is fueling Virginia\u2019s rise as a national biotech leader.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Media Contact<\/b><br \/>Tonia Maistros<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x6d;&#101;&#x64;&#105;&#x61;&#64;&#x62;u&#x69;l&#x74;d&#x6e;a&#x2e;c&#111;&#x6d;\" rel=\"nofollow\" shape=\"rect\">&#x6d;e&#x64;&#105;a&#x40;&#98;&#x75;&#105;l&#x74;&#100;&#x6e;&#97;&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CHARLOTTESVILLE, Va.&#8211;(BUSINESS WIRE)&#8211;BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia\u2019s biotechnology ecosystem. The relocation of BUILT\u2019s headquarters to CvilleBioHub\u2019s state-of-the-art facilities at North Fork Research Park positions the company to rapidly scale production in a &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61971","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHARLOTTESVILLE, Va.&#8211;(BUSINESS WIRE)&#8211;BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia\u2019s biotechnology ecosystem. The relocation of BUILT\u2019s headquarters to CvilleBioHub\u2019s state-of-the-art facilities at North Fork Research Park positions the company to rapidly scale production in a ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-03T20:02:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand\",\"datePublished\":\"2025-10-03T20:02:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/\"},\"wordCount\":524,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251003054308\\\/en\\\/2599452\\\/22\\\/BUILT-logo-black.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/\",\"name\":\"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251003054308\\\/en\\\/2599452\\\/22\\\/BUILT-logo-black.jpg\",\"datePublished\":\"2025-10-03T20:02:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251003054308\\\/en\\\/2599452\\\/22\\\/BUILT-logo-black.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20251003054308\\\/en\\\/2599452\\\/22\\\/BUILT-logo-black.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/","og_locale":"en_US","og_type":"article","og_title":"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand - Pharma Trend","og_description":"CHARLOTTESVILLE, Va.&#8211;(BUSINESS WIRE)&#8211;BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia\u2019s biotechnology ecosystem. The relocation of BUILT\u2019s headquarters to CvilleBioHub\u2019s state-of-the-art facilities at North Fork Research Park positions the company to rapidly scale production in a ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/","og_site_name":"Pharma Trend","article_published_time":"2025-10-03T20:02:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand","datePublished":"2025-10-03T20:02:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/"},"wordCount":524,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/","url":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/","name":"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg","datePublished":"2025-10-03T20:02:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20251003054308\/en\/2599452\/22\/BUILT-logo-black.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/built-biotechnologies-named-commonwealth-bioaccelerator-anchor-company-as-emerging-leader-in-dna-manufacturing-as-service-scales-to-meet-exploding-demand\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"BUILT Biotechnologies Named Commonwealth BioAccelerator Anchor Company As Emerging Leader in DNA Manufacturing-as-Service Scales to Meet Exploding Demand"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61971","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61971"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61971\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61971"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61971"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61971"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}